Search Page

1

Cite

Share

Perspectives of breast cancer etiology: synergistic interaction between smoking and exogenous hormone use.

Zhu HH, Hu CH, Strickland P. Zhu HH, et al. Chin J Cancer. 2011 Jul;30(7):433-41. doi: 10.5732/cjc.010.10534. Chin J Cancer. 2011. PMID: 21718589 Free PMC article.

Cite

Share

2

Cite

Share

Solitary fibrous tumors of the pleura with Doege-Potter syndrome: a case report and three-decade review of the literature.

Meng W, Zhu HH, Li H, Wang G, Wei D, Feng X. Meng W, et al. Among authors: zhu hh. BMC Res Notes. 2014 Aug 11;7:515. doi: 10.1186/1756-0500-7-515. BMC Res Notes. 2014. PMID: 25113505 Free PMC article. Review.

Cite

Share

3

Cite

Share

[Effects of Iron Intensity-regulated Root Microbial Community Structure and Function on Cadmium Accumulation in Rice].

Zheng S, Huang DY, Li B, Ma TC, Xu C, Zhu QH, Zhu HH, Zhang Q. Zheng S, et al. Among authors: zhu hh. Huan Jing Ke Xue. 2022 Aug 8;43(8):4313-4321. doi: 10.13227/j.hjkx.202110165. Huan Jing Ke Xue. 2022. PMID: 35971727 Chinese.

Cite

Share

4

Cite

Share

National surveillance of hookworm disease in China: A population study.

Zhu HH, Huang JL, Chen YD, Zhou CH, Zhu TJ, Qian MB, Zhang MZ, Li SZ, Zhou XN. Zhu HH, et al. PLoS Negl Trop Dis. 2022 Jun 9;16(6):e0010405. doi: 10.1371/journal.pntd.0010405. eCollection 2022 Jun. PLoS Negl Trop Dis. 2022. PMID: 35679319 Free PMC article.

Cite

Share

5

Cite

Share

Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer.

Cheng C, Wang J, Xu P, Zhang K, Xin Z, Zhao H, Ji Z, Zhang M, Wang D, He Y, Jing N, Fan L, Liu K, Li F, Liu C, Gong Y, Cui S, Sun Z, Sun D, Yao X, Li H, Zhang J, Zhang P, Dong B, Xue W, Qian X, Gao WQ, Zhu HH. Cheng C, et al. Among authors: zhu hh. Nat Cancer. 2022 May;3(5):565-580. doi: 10.1038/s43018-022-00380-3. Epub 2022 May 27. Nat Cancer. 2022. PMID: 35624341

Cite

Share

6

Cite

Share

PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to As₂O₃ by stabilizing oncoprotein PML-RARα.

Huang X, Yang Y, Zhu D, Zhao Y, Wei M, Li K, Zhu HH, Zheng X. Huang X, et al. Among authors: zhu hh. Cell Mol Life Sci. 2022 May 27;79(6):319. doi: 10.1007/s00018-022-04358-3. Cell Mol Life Sci. 2022. PMID: 35622143

Cite

Share

7

Cite

Share

[Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].

Zhu WJ, Zhu HH, Liu YT, Lin L, Xing PY, Hao XZ, Cong MH, Wang HY, Wang Y, Li JL, Feng Y, Hu XS. Zhu WJ, et al. Among authors: zhu hh. Zhonghua Zhong Liu Za Zhi. 2022 May 23;44(5):416-424. doi: 10.3760/cma.j.cn112152-20210709-00504. Zhonghua Zhong Liu Za Zhi. 2022. PMID: 35615798 Chinese.

Cite

Share

8

Cite

Share

A real-world study of infectious complications of venetoclax combined with decitabine or azacitidine in adult acute myeloid leukemia.

Zhu LX, Chen RR, Wang LL, Sun JN, Zhou D, Li L, Qian JJ, Zhang Y, Tong HY, Yu WJ, Meng HT, Mai WY, Xie WZ, Jin J, Ye XJ, Zhu HH. Zhu LX, et al. Among authors: zhu hh. Support Care Cancer. 2022 Aug;30(8):7031-7038. doi: 10.1007/s00520-022-07126-y. Epub 2022 May 19. Support Care Cancer. 2022. PMID: 35585204

Cite

Share

9

Cite

Share

[Quantitative evaluation of global left ventricular myocardial work in patients with hepatitis B cirrhosis by pressure-strain loop].

Zhang HH, Zhu HH, Zhang XJ, Li SS, Zhang M, Li S, Guo W, Sun SW, Yuan JJ. Zhang HH, et al. Among authors: zhu hh. Zhonghua Gan Zang Bing Za Zhi. 2022 Apr 20;30(4):402-406. doi: 10.3760/cma.j.cn501113-20210628-00305. Zhonghua Gan Zang Bing Za Zhi. 2022. PMID: 35545565 Chinese.

Cite

Share

10

Cite

Share

Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial.

Wang H, Mao L, Yang M, Qian P, Lu H, Tong H, Xie W, Zhou D, Huang X, Wang Y, Xu G, Lu Y, Wei J, Mai W, Ye X, Meng H, Shen Y, Huang J, Yu W, Sun J, Sheng J, Yan X, Jin J, Zhu HH. Wang H, et al. Among authors: zhu hh. Lancet Haematol. 2022 Jun;9(6):e415-e424. doi: 10.1016/S2352-3026(22)00106-5. Epub 2022 May 2. Lancet Haematol. 2022. PMID: 35512726 Clinical Trial.

Cite

Share